10-Q: Acme United Corp Reports Slight Sales Increase in Q1 2025, Cites Tariff and Economic Concerns

Acme United Corporation's Q1 2025 net sales increased by 2% compared to Q1 2024, with growth in the U.S. and Canada offset by a decline in Europe, while the company addresses internal control weaknesses and monitors tariff impacts.

Summary

• Acme United Corporation reported a 2% increase in net sales for the three months ended March 31, 2025, reaching $45.958 million compared to $44.956 million in the same period of 2024.
• U.S. net sales increased by 3%, driven by higher sales of first aid and medical products, but offset by lower sales of school and office products due to a large prior-year order.
• Canadian net sales increased by 5% in U.S. dollars and 12% in local currency, with strong first aid product sales offset by a soft economy impacting school and office product sales.
• European net sales decreased by 7% in U.S. dollars and 4% in local currency, primarily due to a large promotion in Q1 2024 that was not repeated.
• Gross profit increased to $17.917 million (39.0% of net sales) from $17.396 million (38.7% of net sales) due to higher sales.
• Selling, general, and administrative expenses increased to $15.491 million (33.7% of net sales) from $14.838 million (33.0% of net sales), primarily due to higher personnel-related expenses.
• Operating income decreased to $2.426 million from $2.558 million, with varying performance across segments.
• Net interest expense decreased to $397,000 from $443,000 due to lower average outstanding borrowings and interest rates.
• The effective income tax rate was 22% compared to 24% in the same period of 2024.
• Working capital increased by approximately $4.2 million during the first three months of 2025.
• The company is addressing a material weakness in its information technology general controls related to logical security and privileged access management.
• The company expects to mitigate the potential impact of tariffs through strategic sourcing adjustments, price adjustments, and supply chain diversification.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While sales increased and the company is addressing challenges, there are also risks related to tariffs and economic conditions. The identification of a material weakness in internal controls is a concern.

Positives

• Net sales increased by 2% overall.
• U.S. and Canadian sales showed growth.
• Gross profit margin improved slightly.
• Interest expense decreased due to lower average outstanding borrowings and interest rates.
• The company is taking steps to address a material weakness in IT general controls.
• The company is actively managing the impact of tariffs through strategic sourcing and price adjustments.

Negatives

• European sales decreased by 7% in U.S. dollars.
• Operating income decreased from $2.558 million to $2.426 million.
• SG&A expenses increased by $653,000 due to higher personnel costs.
• A material weakness in IT general controls was identified.
• The company faces risks associated with tariffs, global economic conditions, and supply chain disruptions.

Risks

• The company faces risks associated with the 145% tariff on goods sourced from China and other potential tariff changes.
• Uncertainties in global economic conditions could impact suppliers and customers.
• Inflation, including product costs, transportation costs, and interest rates, could have an adverse impact.
• Wars in Ukraine and the Middle East could have potential adverse effects on the company, its customers, and suppliers.
• Additional disruptions in the company's supply chains could occur due to pandemics, natural disasters, or other factors.
• Labor-related costs, including acquiring and training new employees and rising wages and benefits, could increase.
• Currency fluctuations could impact financial results.
• The company's ability to effectively manage its inventory in a rapidly changing business environment is a risk.
• Competition and technological changes, including the growth of online marketing and sales activity, could pose challenges.
• The company's ability to manage its growth effectively, including integrating acquired businesses, is a risk.

Future Outlook

The Company believes that cash generated from operating activities, together with funds available under its revolving loan agreement, will, under current conditions, be sufficient to finance the Company's operations over the next twelve months from the filing of this report.

Management Comments

• The increase in net sales for the three months ended March 31, 2025 was primarily due to higher sales of first aid and medical products partially offset by lower sales of school and office products.
• The decrease in interest expense for the three months ended March 31, 2025 resulted from lower average outstanding borrowings as well as lower average interest rates on the debt outstanding.

Industry Context

Acme United operates in the first aid and medical products, and cutting and sharpening tools industries, which are influenced by factors such as consumer spending, economic conditions, and global trade policies. The company's performance is affected by competition, technological changes, and supply chain dynamics.

Comparison to Industry Standards

• It is difficult to compare Acme United directly to industry standards without specific competitor data.
• However, the company's gross profit margin of 39.0% can be benchmarked against other companies in the consumer goods and medical supplies sectors.
• Inventory turnover of 2.1 is a key metric to compare against peers to assess efficiency in managing inventory.
• The long-term debt to equity ratio of 27.9% provides insight into the company's financial leverage compared to industry averages.

Corporate Governance

Legal Proceedings

• There are no pending material legal proceedings to which the Company is a party, or, to the actual knowledge of the Company, contemplated by any governmental authority.

Stakeholder Impact

• Shareholders: The slight increase in sales and earnings per share could be viewed positively, but the identified material weakness in internal controls may raise concerns.
• Employees: Higher personnel-related expenses suggest potential investments in employees, but the company's overall performance and economic risks could impact job security.
• Customers: The company's ability to manage tariffs and supply chain disruptions will impact product availability and pricing.
• Suppliers: Global economic conditions and trade policies could affect the company's sourcing strategies and relationships with suppliers.
• Creditors: The company's compliance with covenants under the revolving loan agreement is positive, but the long-term debt to equity ratio should be monitored.

Next Steps

• The company will continue to monitor and manage the impact of tariffs and global economic conditions.
• The company will work to remediate the material weakness in IT general controls by December 31, 2025.
• The company will focus on strategic sourcing adjustments, price adjustments, and supply chain diversification to mitigate risks.
• The company will continue to evaluate the impact of adopting ASU 2023-09 and ASU 2024-03 on its consolidated financial statements and related disclosures.

Key Dates

Keywords

net sales, first aid, tariffs, medical products, financial results, operating income, internal controls, supply chain, Acme United, sales